Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Noncompliance with antihypertensive therapy. Economic consequences.

× No keyword cloud information.

59 in total

1. How often is medication taken as prescribed? A novel assessment technique.

Authors: J A Cramer; R H Mattson; M L Prevey; R D Scheyer; V L Ouellette
Journal: JAMA Date: 1989-06-09 Impact factor: 56.272

2. Translating safety, efficacy and compliance into economic value for controlled release dosage forms.

Authors: M P Cramer; S R Saks
Journal: Pharmacoeconomics Date: 1994-06 Impact factor: 4.981

Review 3. Oil and water? Economic advantage and biomedical progress do not mix well in a government guidelines committee.

Authors: J Ménard
Journal: Am J Hypertens Date: 1994-10 Impact factor: 2.689

4. The patient's view of hypertension and compliance.

Authors: C M Sharkness; D A Snow
Journal: Am J Prev Med Date: 1992 May-Jun Impact factor: 5.043

5. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors:
Journal: JAMA Date: 1991-06-26 Impact factor: 56.272

6. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.

Authors: P Sever; G Beevers; C Bulpitt; A Lever; L Ramsay; J Reid; J Swales
Journal: BMJ Date: 1993-04-10

Review 7. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data.

Authors: J Stamler; R Stamler; J D Neaton
Journal: Arch Intern Med Date: 1993-03-08

8. 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee.

Authors:
Journal: Hypertension Date: 1993-09 Impact factor: 10.190

Review 9. Hypertension, cardiac disease, and compliance in minority patients.

Authors: C K Francis
Journal: Am J Med Date: 1991-07-18 Impact factor: 4.965

Review 10. Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines.

Authors: L Tobian; H R Brunner; J N Cohn; H Gavras; J H Laragh; B J Materson; M A Weber
Journal: Am J Hypertens Date: 1994-10 Impact factor: 2.689

8 in total

Review 1. Pharmacoeconomics of hypertension management: the place of combination therapy.

Authors: E Ambrosioni
Journal: Pharmacoeconomics Date: 2001 Impact factor: 4.981

2. The role of religion in relation to blood pressure control among a Southern California Thai population with hypertension.

Authors: Supaporn Naewbood; Siroj Sorajjakool; Somporn Kantharadussadee Triamchaisri
Journal: J Relig Health Date: 2012-03

Review 3. Pharmacoeconomic burden of undertreating hypertension.

Authors: Luca Degli Esposti; Giorgia Valpiani
Journal: Pharmacoeconomics Date: 2004 Impact factor: 4.981

Review 4. [Socioeconomic and quality of life repercussions of arterial hypertension].

Authors: B Selke; P Marquis; T Lebrun
Journal: Drugs Date: 1998 Impact factor: 9.546

5. Pharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapies.

Authors: Luca Degli Esposti; Mirko Di Martino; Stefania Saragoni; Andrea Sgreccia; Alessandro Capone; Stefano Buda; Ezio Degli Esposti
Journal: J Clin Hypertens (Greenwich) Date: 2004-02 Impact factor: 3.738

Review 6. Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment--a review.

Authors: Peter Bramlage; Joerg Hasford
Journal: Cardiovasc Diabetol Date: 2009-03-27 Impact factor: 9.951

Review 7. The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review.

Authors: N Muszbek; D Brixner; A Benedict; A Keskinaslan; Z M Khan
Journal: Int J Clin Pract Date: 2008-02 Impact factor: 2.503

8. Discontinuation of anti-hypertensive drugs increases 11-year cardiovascular mortality risk in community-dwelling elderly (the Bambuí Cohort Study of Ageing).

Authors: Maria Lea Correa Leite; Joselia O A Firmo; Antonio Ignacio Loyola Filho; Maria Fernanda Lima-Costa
Journal: BMC Public Health Date: 2014-07-16 Impact factor: 3.295

8 in total